These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11862392)

  • 1. Lack of a consistent relationship between demethylation of the CD44 promoter and CD44 expression.
    Hyman R
    Immunogenetics; 2002 Feb; 53(10-11):914-24. PubMed ID: 11862392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma.
    Yan P; Mühlethaler A; Bourloud KB; Beck MN; Gross N
    Genes Chromosomes Cancer; 2003 Feb; 36(2):129-38. PubMed ID: 12508241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of methylation inhibitor on demethylation pattern of the PD-1 gene in promoter region and PD-1 expression in human T lymphocyte cell line].
    Zhang M; Xiao X; Liang Y; Peng M; Jiang Y; Xu Y; Gong G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1163-9. PubMed ID: 22246361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP.
    Abecassis I; Maes J; Carrier JL; Hillion J; Goodhardt M; Medjber K; Wany L; Lanotte M; Karniguian A
    Leukemia; 2008 Mar; 22(3):511-20. PubMed ID: 18094716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes: regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells.
    Fitzpatrick DR; Shirley KM; McDonald LE; Bielefeldt-Ohmann H; Kay GF; Kelso A
    J Exp Med; 1998 Jul; 188(1):103-17. PubMed ID: 9653088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
    Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
    Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
    Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
    Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
    Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3.
    Archey WB; Sweet MP; Alig GC; Arrick BA
    Cancer Res; 1999 May; 59(10):2292-6. PubMed ID: 10344731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines.
    Honoki K; Tsujiuchi T; Mori T; Yoshitani K; Tsutsumi M; Takakura Y; Mii Y
    Mol Carcinog; 2004 Jan; 39(1):10-4. PubMed ID: 14694443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SVEP1 promoter regulation by methylation of CpG sites.
    Glait-Santar C; Benayahu D
    Gene; 2011 Dec; 490(1-2):6-14. PubMed ID: 21963386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
    Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CpG methylation in cell type-specific expression of the aquaporin-5 gene.
    Nomura J; Hisatsune A; Miyata T; Isohama Y
    Biochem Biophys Res Commun; 2007 Feb; 353(4):1017-22. PubMed ID: 17198683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic control of expression of the human L- and M- pigment genes.
    Deeb SS; Bisset D; Fu L
    Ophthalmic Physiol Opt; 2010 Sep; 30(5):446-53. PubMed ID: 20883327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.